Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1720-1725

  Ito, Mina ^a   Nagai, Taku ^a,b   Kamei, Hiroyuki ^a   Nakamichi, Noritaka ^a   Nabeshima, Toshitaka ^a,b   Takuma, Kazuhiro ^a   Yamada, Kiyofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ARTICLE; DEPOLARIZATION; DOPAMINE RELEASE; DOSE RESPONSE; EVOKED RESPONSE; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; WILD TYPE;

ACETYLCHOLINE; ANIMALS; DOPAMINE; HIPPOCAMPUS; HUMANS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NUCLEUS ACCUMBENS; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33751173660     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.022467     Document Type: Article

References (38)

1. Abi-Dargham A and Moore H (2003) Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9:404-416.
2. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, and Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathways. Neuron 21:813-825.
3. 2+ influx and neurite growth in response to purified N-cadherin and laminin. J Cell Biol 127:1461-1475.
4. Blochl A and Sirrenberg C (1996) Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem 271:21100-21107.
5. Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, et al. (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002-1012.
6. Chen ZL, Indyk JA, and Strickland S (2003) The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell 14:2665-2676.
7. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, and Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24:4401-4411.
8. Dery O, Corvera CU, Steinhoff M, and Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:C1429-C1452.
9. Franklin JBJ and Paxinos GT (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, New York.
10. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45:489-496.
11. Goldfinger LE, Jiang L, Hopkinson SB, Stack MS, and Jones JC (2000) Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the α3 subunit of laminin-5. J Biol Chem 275:34887-34893.
12. Grand RJ, Turnell AS, and Grabham PW (1996) Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368.
13. Gualandris A, Jones TE, Strickland S, and Tsirka SE (1996) Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16:2220-2225.
14. Jin G, Tan X, Tian M, Qin J, Zhu H, Huang Z, and Xu H (2005) The controlled differentiation of human neural stem cells into TH-immunoreactive (ir) neurons in vitro. Neurosci Lett 386:105-110.
15. Johansen EB and Sagvolden T (2005) Behavioral effects of intra-cranial self-stimulation in an animal model of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Res 162:32-46.
16. Koob GF and Weiss F (1992) Neuropharmacology of cocaine and ethanol dependence. Recent Dev Alcohol 10:201-233.
17. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, and Costello CE (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38:4572-4585.
18. Loskutoff DJ, Sawdey M, and Mimuro J (1989) Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 9:87-115.
19. Matys T, Pawlak R, Matys E, Pavlides C, McEwen BS, and Strickland S (2004) Tissue plasminogen activator promotes the effects of corticotropin- releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci USA 101:16345-16350.
20. Nagai T, Kamei H, Ito M, Hashimoto K, Takuma K, Nabeshima T, and Yamada K (2005a) Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice. J Neurochem 93:1272-1279.
21. Nagai T, Noda Y, Ishikawa K, Miyamoto Y, Yoshimura M, Ito M, Takayanagi M, Takuma K, Yamada K, and Nabeshima T (2005b) The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J Neurochem 92:660-667.
22. Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, Noda Y, Nitta A, and Nabeshima T (2004) The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA 101:3650-3655.
23. Nakagami Y, Abe K, Nishiyama N, and Matsuki N (2000) Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20:2003-2010.
24. Nilsson OG, Kalen P, Rosengren E, and Bjorklund A (1990) Acetylcholine release in the rat hippocampus as studied by microdialysis is dependent on axonal impulse flow and increases during behavioural activation. Neuroscience 36:325-338.
25. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, and Lu B (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science (Wash DC) 306:487-491.
26. Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, and Miles LA (1997) Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem 272:1976-1982.
27. Pontieri FE, Tanda G, Orzi F, and Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (Lond) 382:255-257.
28. Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24-32.
29. Salles FJ and Strickland S (2002) Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci 22:2125-2134.
30. Seeds NW, Basham ME, and Haffke SP (1999) Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci USA 96:14118-14123.
31. Seeman P, Lee T, Chau-Wong M, and Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (Lond) 261:717-719.
32. Sunderland WJ, Son YJ, Miner JH, Sanes JR, and Carlson SS (2000) The presynaptic calcium channel is part of a transmembrane complex linking a synaptic laminin (α4β2γ1) with non-erythroid spectrin. J Neurosci 20:1009-1019.
33. Tarazi FI (2001) Neuropharmacology of dopamine receptors: implications in neuropsychiatric diseases. Med Sci 3:93-104.
34. Tran MH, Yamada K, Olariu A, Mizuno M, Ren XH, and Nabeshima T (2001) Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 15:1407-1409.
35. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, and Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121.
36. Vu TK, Hung DT, Wheaton VI, and Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
37. Weinstein JR, Gold SJ, Cunningham DD, and Gall CM (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15:2906-2919.
38. Yamada K, Nagai T, and Nabeshima T (2005) Tissue plasminogen activator, synaptic plasticity and drug addiction. J Pharmacol Sci 97:157-161.